These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20353975)

  • 1. The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome.
    de Groot PG; Derksen RH; Urbanus RT
    Lupus; 2010 Apr; 19(4):389-93. PubMed ID: 20353975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some antiphospholipid antibodies bind to various serine proteases in hemostasis and tip the balance toward hypercoagulant states.
    Chen PP; Wu M; Hahn BH
    Lupus; 2010 Apr; 19(4):365-9. PubMed ID: 20353971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of antiphospholipid antibodies.
    de Groot PG; Derksen RH
    Neth J Med; 2004 Sep; 62(8):267-72. PubMed ID: 15588066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New insights on disorders of haemostasis in the antiphospholipid syndrome].
    Zawilska K
    Pol Arch Med Wewn; 2006 May; 115(5):491-9. PubMed ID: 17195368
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiphospholipid antibody profile: implications for the evaluation and management of patients.
    Tincani A; Andreoli L; Casu C; Cattaneo R; Meroni P
    Lupus; 2010 Apr; 19(4):432-5. PubMed ID: 20353983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Blood Rev; 2008 Mar; 22(2):93-105. PubMed ID: 17964017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets and the antiphospholipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice.
    Roubey RA
    Lupus; 2010 Apr; 19(4):440-5. PubMed ID: 20353985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiphospholipid syndrome: clinical characteristics, laboratory features and pathogenesis.
    de Groot PG; Derksen RH
    Curr Opin Infect Dis; 2005 Jun; 18(3):205-10. PubMed ID: 15864096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies: lessons from the bench.
    Koike T; Bohgaki M; Amengual O; Atsumi T
    J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies and the protein C pathway.
    Urbanus RT; de Laat B
    Lupus; 2010 Apr; 19(4):394-9. PubMed ID: 20353976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.
    Matsuura E; Shen L; Matsunami Y; Quan N; Makarova M; Geske FJ; Boisen M; Yasuda S; Kobayashi K; Lopez LR
    Lupus; 2010 Apr; 19(4):379-84. PubMed ID: 20353973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in our understanding of the antiphospholipid syndrome.
    De Groot PG; Meijers JC; Urbanus RT
    Int J Lab Hematol; 2012 Jun; 34(3):223-31. PubMed ID: 22394675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
    de Laat B; Mertens K; de Groot PG
    Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
    Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
    Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.